Novel form of rhizomelic skeletal dysplasia associated with a homozygous variant in


Journal

Journal of medical genetics
ISSN: 1468-6244
Titre abrégé: J Med Genet
Pays: England
ID NLM: 2985087R

Informations de publication

Date de publication:
05 2021
Historique:
received: 20 02 2020
revised: 18 05 2020
accepted: 21 05 2020
pubmed: 28 6 2020
medline: 19 1 2022
entrez: 28 6 2020
Statut: ppublish

Résumé

Studies exploring molecular mechanisms underlying congenital skeletal disorders have revealed novel regulators of skeletal homeostasis and shown protein glycosylation to play an important role. To identify the genetic cause of rhizomelic skeletal dysplasia in a consanguineous Pakistani family. Clinical investigations were carried out for four affected individuals in the recruited family. Whole genome sequencing (WGS) was completed using DNA from two affected and two unaffected individuals from the family. Sequencing data were processed, filtered and analysed. In silico analyses were performed to predict the effects of the candidate variant on the protein structure and function. Small interfering RNAs (siRNAs) were used to study the effect of The patients presented with short stature due to extreme shortening of the proximal segments of the limbs. Radiographs of one individual showed hip dysplasia and severe platyspondyly. WGS data analyses identified a homozygous missense variant c.226G>A; p.(Glu76Lys) in This study describes a novel severe skeletal dysplasia associated with a biallelic, variant in

Sections du résumé

BACKGROUND
Studies exploring molecular mechanisms underlying congenital skeletal disorders have revealed novel regulators of skeletal homeostasis and shown protein glycosylation to play an important role.
OBJECTIVE
To identify the genetic cause of rhizomelic skeletal dysplasia in a consanguineous Pakistani family.
METHODS
Clinical investigations were carried out for four affected individuals in the recruited family. Whole genome sequencing (WGS) was completed using DNA from two affected and two unaffected individuals from the family. Sequencing data were processed, filtered and analysed. In silico analyses were performed to predict the effects of the candidate variant on the protein structure and function. Small interfering RNAs (siRNAs) were used to study the effect of
RESULTS
The patients presented with short stature due to extreme shortening of the proximal segments of the limbs. Radiographs of one individual showed hip dysplasia and severe platyspondyly. WGS data analyses identified a homozygous missense variant c.226G>A; p.(Glu76Lys) in
CONCLUSIONS
This study describes a novel severe skeletal dysplasia associated with a biallelic, variant in

Identifiants

pubmed: 32591345
pii: jmedgenet-2020-106929
doi: 10.1136/jmedgenet-2020-106929
doi:

Substances chimiques

GNPNAT1 protein, human EC 2.3.1.4
Glucosamine 6-Phosphate N-Acetyltransferase EC 2.3.1.4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

351-356

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Noor Ul Ain (NU)

School of Biological Sciences, University of the Punjab, Lahore, Pakistan.
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Marta Baroncelli (M)

Center for Molecular Medicine and Pediatric Endocrinology Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.

Alice Costantini (A)

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Tayyaba Ishaq (T)

School of Biological Sciences, University of the Punjab, Lahore, Pakistan.

Fulya Taylan (F)

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Ola Nilsson (O)

Center for Molecular Medicine and Pediatric Endocrinology Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
School of Medical Sciences, Örebro University and Örebro University Hospital, Örebro, Sweden.

Outi Mäkitie (O)

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden naz.sbs@pu.edu.pk outi.makitie@helsinki.fi.
Children's Hospital, University of Helsinki, Helsinki, Finland.
Folkhälsan Institute of Genetics, Helsinki, Finland.

Sadaf Naz (S)

School of Biological Sciences, University of the Punjab, Lahore, Pakistan naz.sbs@pu.edu.pk outi.makitie@helsinki.fi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH